Investor Presentaiton slide image

Investor Presentaiton

Group Financial Results for the year ended 31 December 2020 €1.4 bn NPE sales agreed since Dec 2019, reducing NPE ratio to 16%¹ • Helix 2 Portfolio B 43% NPE reduction 9 p.p. reduction in NPE ratio • Agreement for the sale of €529 mn NPES (with reference date 30 Sep 2020) in Jan 2021 Gross consideration of 44% of gross book value (based on 30 Sep 2020) and 31% of contractual balance³, payable in cash, of which 50% is deferred unconditionally up to Dec 2025 NPES (€ bn) -43% 3.1 • Loss of €27 mn recorded in 4Q2020 1.8 NPE ratio -9 p.p. 25% 16% Helix 2 Portfolio A Agreement for the sale of €886 mn NPES (with reference date 30 Jun 2020) in Aug 2020 Gross consideration of 46% of gross book value (based on 30 Jun 2020) and 29% of contractual balance³, payable in cash, of which 65% is deferred unconditionally to 3 broadly equal instalments over 48 months Loss of €68 mn recorded in 2Q2020 Dec 2020 Dec 2020 pro forma Dec 2020 for Helix 2¹ Dec 2020 pro forma for Helix 21 CET1 ratio at 15.2% 2 pro forma for Helix 21 14.3% 14.8% 15.2% 15.8% (1) Calculations on a pro forma basis assume legal completion of both Helix 2 Portfolio A and Helix 2 Portfolio B (2) Allowing for IFRS 9 and temporary treatment for certain FVOCI instruments transitional arrangements (3) As at 30 September 2019 (4) Deferred Purchase Price Bank of Cyprus Holdings III Jun 2020 Dec 2020 Dec 2020 Dec 2020 pro forma post DPP for Helix 2¹ payment 4 Total CET1 impact +24 bps: -76 bps already included in FY2020 +34 bps on completion +66 bps upon full payment of deferred consideration 31
View entire presentation